BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 22384625)

  • 1. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis].
    Tomusiak A; Strus M; Heczko PB
    Ginekol Pol; 2011 Dec; 82(12):900-4. PubMed ID: 22384625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
    Tosun I; Alpay Karaoğlu S; Ciftçi H; Buruk CK; Aydin F; Kiliç AO; Ertürk M
    Mikrobiyol Bul; 2007 Jan; 41(1):21-7. PubMed ID: 17427549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic resistance of Gardnerella vaginalis in recurrent bacterial vaginosis.
    Nagaraja P
    Indian J Med Microbiol; 2008; 26(2):155-7. PubMed ID: 18445953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis.
    Cavera VL; Volski A; Chikindas ML
    Probiotics Antimicrob Proteins; 2015 Jun; 7(2):164-71. PubMed ID: 25588687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent bacterial vaginosis unresponsive to metronidazole: successful treatment with oral clindamycin.
    Tepper RS; Ives TJ; Kebede M
    J Am Board Fam Pract; 1994; 7(5):431-2. PubMed ID: 7810359
    [No Abstract]   [Full Text] [Related]  

  • 6. [Susceptibility to antibiotics of microorganisms related with recurrent bacterial vaginosis].
    Shopova E; Nikolov A; Dimitrov A
    Akush Ginekol (Sofiia); 2011; 50(7):20-1. PubMed ID: 22452174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of intrinsically metronidazole-resistant clades of Gardnerella vaginalis.
    Schuyler JA; Mordechai E; Adelson ME; Sobel JD; Gygax SE; Hilbert DW
    Diagn Microbiol Infect Dis; 2016 Jan; 84(1):1-3. PubMed ID: 26514076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy.
    Bradshaw CS; Tabrizi SN; Fairley CK; Morton AN; Rudland E; Garland SM
    J Infect Dis; 2006 Sep; 194(6):828-36. PubMed ID: 16941351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gardnerella vaginalis in infections of reproductive organs].
    Kasprowicz A; Białecka A
    Med Dosw Mikrobiol; 1993; 45(2):199-203. PubMed ID: 8309297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gardnerella vaginalis: transport, microscopy, testing resistance].
    Altrichter T; Heizmann WR
    Geburtshilfe Frauenheilkd; 1994 Nov; 54(11):606-11. PubMed ID: 8719002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiologic response to treatment of bacterial vaginosis with topical clindamycin or metronidazole.
    Austin MN; Beigi RH; Meyn LA; Hillier SL
    J Clin Microbiol; 2005 Sep; 43(9):4492-7. PubMed ID: 16145097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream.
    Ferris DG; Litaker MS; Woodward L; Mathis D; Hendrich J
    J Fam Pract; 1995 Nov; 41(5):443-9. PubMed ID: 7595261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gardnerella vaginalis isolated from patients with bacterial vaginosis and from patients with healthy vaginal ecosystems.
    Aroutcheva AA; Simoes JA; Behbakht K; Faro S
    Clin Infect Dis; 2001 Oct; 33(7):1022-7. PubMed ID: 11528575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Gardnerella vaginalis by lactobacilli.
    Sethi S; Das A; Sharma M
    Int J Gynaecol Obstet; 2006 May; 93(2):158-9. PubMed ID: 16603163
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on Gardnerella vaginitis.
    Schell CL; Harris JH; Honkanen AA; Edwards MS; Raia TJ
    Mil Med; 1992 Jan; 157(1):37-40. PubMed ID: 1603376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models.
    Thellin O; Zorzi W; Zorzi D; Delvenne P; Heinen E; ElMoualij B; Quatresooz P
    Int Microbiol; 2016 Jun; 19(2):101-107. PubMed ID: 27845497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.
    Hymes SR; Randis TM; Sun TY; Ratner AJ
    J Infect Dis; 2013 May; 207(10):1491-7. PubMed ID: 23431033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A biotype study of Gardnerella vaginalis isolated from patients with and without symptoms of bacterial vaginosis].
    Barberis IL; Pájaro MC; Daniele ML; Godino S; Pascual L
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):506-8. PubMed ID: 10650646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens.
    Algburi A; Zhang Y; Weeks R; Comito N; Zehm S; Pinto J; Uhrich KE; Chikindas ML
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.